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Abstract 
To improve the biological performance of hydroxyapatite scaffolds in bone tissue engineering, 
graphite was used as porogen to create additional micro/nanoporosity to macroporosity, resulting in 
hierarchical porosity. For maximum imitation of natural bone structures, scaffolds with different 
porosity features were fabricated using micron/nano-sized graphite. The sintering profile of graphite 
treated scaffolds was optimised to reduce the influence of shrinkage. To confirm the porosity features, 
the micro/nanostructures of scaffolds were characterised by scanning electron microscopy and 
Brunauer-Emmett-Teller method. Considering that hydroxyapatite is resistant to biodegradation in 
vivo, the degradation rate of scaffolds in modified simulated body fluid was examined. Furthermore, 
biological evaluations based on myoblasts were carried out to investigate the influence of porosity 
features on the essential performance such as adhesion, proliferation and differentiation. The results 
indicate that the scaffolds with dominant microporosity and little nanoporosity formed inside had 
high potential for clinical applications due to improved performance in bioactivity. 
Keywords: hydroxyapatite scaffold; hierarchical porosity; porosity feature; biological performance; 
bone tissue engineering. 
 
1. Introduction 
Apart from high porosity, complex and three-dimensional structures [1], biological performance in 
terms of biodegradable ability and bioactivity is also essential for scaffolds to achieve satisfactory 
regeneration in bone tissue engineering [2]. Owing to its similarity to the natural bones in chemical 
composition, HA (hydroxyapatite, Ca10[PO4]6[OH]2) has become an excellent biomaterial as 
substitutes of natural bones [3-6]. However, the uses of HA for bone regenesis have encountered a 
number of technical challenges, including its resistance to biodegradation in vivo [5], low fracture 
toughness, and high crystallinity [3]. Therefore, attempts have been made, e.g. introducing 
conditioners, to modify its performance, thus to overcome certain limitation and satisfy clinical 
needs [4, 7, 8]. So far, the major improvements to HA are concentrated on the material composition, 
with a few considered from the angle of modifying structures to achieve high bio-imitability to 
natural bones. This work is primarily concerned with the potential approaches to fabrication of 3D 
complex structures with hierarchical porosity in HA scaffolds, consisting of nanoporosity, 
microporosity and macroporosity [9], which is expected to further enhance the biological 
performance. 
The importance of porosity and pore structures on osteogenesis had been extensively investigated 
[10-12]. In general, the nanoporosity in scaffolds could significantly promote osteoinductivity during 
bone tissue engineering by enhancing osteogenic differentiation [13, 14], as many natural tissues like 
bone can be regarded as materials with some nanostructures. It was also found that both macro and 
micro porosity could influence osteoinductive activity to certain extent [10, 11]. Particularly, the 
microporosity in the scaffolds is able to make substantial contribution to bone regeneration [15, 16]. 
Adequate microporosity in scaffolds is also necessary to allow in-growth of capillaries to promote 
osteogenesis [15]. As for macroporosity, it forms 3D complex structures, which encourages 
migration and proliferation of osteogenic cells, as well as reinforces mechanical connection with 
adjacent tissues [4, 12, 17]. Nevertheless, it has presented limitations in existing traditional 
technologies due to uncontrollable distribution and sizes of pores in scaffolds [18-20], and recently 
developed 3D printing techniques are not capable of producing microporosity in nano scale [21-23]. 
Hence it is almost impossible to fabricate scaffolds with refined structures consisting of porosity 
across macro, micron and nano scale (nm - μm - mm) through these methods. 
In this study, a new fabrication method combining the extrusion deposition [20] with porogen 
foaming technique was developed to construct highly porous HA scaffolds with evident hierarchical 
porosity [24]. The process is controllable and reproducible; it is able to create a wide range and scale 
of porosities with adjustable distribution in HA scaffolds, meanwhile with suitable mechanical 
strength. However, the scaffolds may exhibit significant difference in features and characteristics of 
hierarchical porosity, e.g. the ratios between microporosity and nanoporosity, which mainly depends 
on the particle size distribution of porogen. Therefore, it is important to evaluate the influence of 
such difference on biological performance of scaffolds in order to optimise the structures through the 
control of particle sizes and distribution of porogen. In this paper, we present the process of graphite 
as pore former to generate in-rod porosity (additional porosity inside the rods of scaffolds), which 
can permit the adjustment of microporosity and nanoporosity with nano graphite (nG) or micron 
graphite (μG). It was highly anticipated that further optimisation is possible to control the 
distribution of porosity in scaffolds, so that acceptable and optimal solution for bone tissue 
engineering may be achieved to meet the needs of clinical applications. 
2. Material and methods 
2.1 Fabrication of scaffolds 
Scaffolds were fabricated by MAM system [20] (motor assisted micro-syringe system; MAM-II, 
Fochif, China) with commercially available nano HA (MH-HAp, Emperor Nano Material, China) 
and graphite powder in micron (300 mesh, Sinopharm Chemical Reagent, China) / nano (~400nm; 
XF011, XF-Nano, China) size if necessary. Scaffolds were then sintered in furnace (KSL-1700, 
Kejing Materials Technology, China) at high temperature (1200°C) [8, 25]. Other reagents used to 
get well dispersed slurry with favourable properties for deposition include glycerol (Sinopharm), 
ammonia water (Sinopharm), nitric acid (Sinopharm) and NH4PAA (ammonium polyacrylate; 
Goodben, China), and dispersant for graphite (HT100, Goodben) [20]. 
On the basis of previous work [24], three kinds of scaffolds, i.e. normal HA for control (marked as 
HA-n-c), HA with 25vol.% micron graphite as pore former (short for HA-μG-25%) and HA with 
25vol.% nano graphite (HA-nG-25%), were prepared for characterization and evaluation in terms of 
microstructures and biological performance. In addition, to reduce the influence of shrinkage on 
in-rod porosity, TGA/DSC (thermo-gravimetric analysis / differential scanning calorimetry; TGA7, 
Perkin Elmer, China) was employed to record the sintering behaviour of normal and graphite treated 
scaffolds (HA-G). 
2.2 Characterization of morphologies 
The particle size of graphite (nG and μG) was measured by dynamic light scattering (DLS) 
nano-particle size analyser (LB550, Horiba Scientific, Japan). Due to poor liquidity, graphite samples 
were dispersed in a solution with ultrasonic vibration. The distribution and size of porosity was 
measured by BET method (Brunauer-Emmett-Teller; ASAP2020, Micromeritics Instrument, USA). 
And SEM (scanning electron microscopy; Nova NanoSEM 450, FEI, Netherlands) was used to 
observe the morphologies of HA scaffolds before and 1 day after cell culture. Prior to SEM, the 
scaffolds after cell culture were washed with phosphate buffered saline (Sinopharm) and later 
critical-point dried [26]. 
2.3 Assessment of biodegradation 
Modified SBF (simulated body fluid) was prepared according to reference [27]. The materials for 
SBF were listed as follows: sodium chloride (AR, 99.5%; Aladdin Bio-Chem, China), sodium 
bicarbonate (AR, ≥99.8%; Aladdin), potassium chloride (AR, 99.5%; Aladdin), potassium 
dihydrogen phosphate (AR, 99%; Aladdin), magnesium chloride hexahydrate (AR, 98.0%; Aladdin), 
calcium chloride (AR, 96.0%; Aladdin), sodium sulphate (AR, 99%; Aladdin), 
tris(hydroxymethyl)aminomethane (≥99.9%; Aladdin), hydrochloric acid (1mol/L; Sinopharm) and 
standard pH solution (Sinopharm). Since HA degrades very slowly in neutral environment [5], the 
SBF used in this study was acidic (pH = 3) to accelerate the degradation process. To make sure that 
the result could offer possible reference to in-vivo environment, the assessment was performed on the 
condition of water bath at 37°C (SHA-C, Hongke Instrument, China).The actual pH and weight loss 
was measured twice a week during the degradation test. Moreover, once the pH of SBF under test 
was larger than 5, the SBF would be renewed to maintain the actual degradation rate. The number of 
scaffolds (HA-n-c, HA-μG-25% and HA-nG-25%) for test was 6 each. 
2.4 Evaluation of bioactivity 
To evaluate the effect of scaffolds on proliferation and cell morphology, C2C12s (myoblasts, a cell 
line with a visually determinable differentiation profile) [28] were incubated in growth media 
consisting of HG-DMEM (high-glucose Dulbecco's modified eagle medium; HyClone, GE 
Healthcare Life Sciences) supplemented with 20% FBS (fetal bovine serum; FBS Biotech, PAN 
Biotech) and 1% P/S (penicillin/streptomycin, 10,000U/mL and 10,000µg/mL; Gibco, Thermo 
Fisher Scientific). C2C12s were exposed to scaffolds until they were confluent (4 days). To test the 
influence on differentiation capacity, C2C12s were grown until confluent in normal growth media (4 
days) and then incubated with differentiation media, i.e. HG-DMEM, 2% donor equine serum 
(HyClone) and 1µM insulin (Sigma-Aldrich), for three days. 
At the end of experiments, cells were lysed or fixed for further analysis in dH2O or methanol and 
acetone (50% v/v; Sigma-Aldrich) respectively. C2C12s used in this study were in passage 3 - 6 and 
seeded at 4500cells/cm
2
 onto tissue culture plastic (DNA/protein analysis) or gelatine-coated (0.2%) 
coverslips (for imaging) set within a 6-well plate. The samples with C2C12s were all incubated in a 
humidified CO2 incubator (Heracell 150i, Thermo Fisher Scientific) at 37°C during the whole 
process. The immucytochemical images were photographed by a fluorescence microscope (D71, 
Olympus, Japan). 
3. Results and discussion 
3.1 Particle size of porogen 
Hierarchical porosity in this paper refers to macroporosity with considerable amount of 
microporosity and nanoporosity inside the rods of scaffolds. The classification of above mentioned 
porosity was based on literatures and dimensions: macroporosity (≥ 100μm, the least required size 
for cell survivability [29, 30]), microporosity (1 ~ 100μm, allowing in-growth of human 
micro-vessels or capillaries [31]) and nanoporosity (< 1μm, significantly promoting osteoinductivity 
through enhancing osteogenic differentiation [13, 14]). 
Based on our experience, the size and shape of chemically formed micropores or nanopores would 
be closely related to the original porogen; that is, after sintering, the in-rod micro- / nano-structures 
of scaffolds are mainly determined by the particle size and distribution of porogen. Therefore, it is of 
great significance to analyse the particle size and distribution of nano and micron graphite so as to 
predict the formation of hierarchical porosity. According to the DLS result shown in Fig.1, the 
particle size of nG was mainly focused on the range of 241 and 872nm (up to 98.6%). The extremum 
(where the probability of size is the highest) and average size of nG was 460 and 477nm respectively, 
meaning that it is reasonable to use such nG to create in-rod nanoporosity. On the other hand, the 
distribution of μG was relatively dispersive, possibly due to the fragility and aggregation of μG 
sample. But the μG particles between 10 and 100μm was still in the majority (over 70%), indicating 
the ability to form considerable in-rod microporosity. Although the extremum (27.4μm) was not 
close to the average size (53.4μm), the size distribution of μG was uniform. Overall, owing to 
uniform distribution of particle size, both nG and μG were suitable as porogen to create additional 
in-rod porosity, which results in hierarchically porous structures. 
3.2 Optimization of sintering process 
It is highly desired that the nanoporosity or microporosity formed by chemical reagents and porogen 
could be preserved as much as possible after sintering at high temperature. In this study, TGA/DSC 
was employed to analyse the sintering behaviour of normal scaffold (0vol.% graphite) and HA-G 
scaffold (25vol.% graphite). And the result was taken as a reference for the optimisation of sintering 
process which was expected to reduce the influence of shrinkage on in-rod porosity. It was found that 
two critical stages regarding weight loss and energy emission, at 220°C and 850°C respectively, 
occurred during the TGA/DSC analysis of HA-G (Fig.2(a)). As for normal scaffolds, there was only 
one critical stage at 220°C. By comparision, it can be concluded that the stage at 220°C in both 
scaffolds was mainly the result of the oxidation of chemical reagents, used for well dispersed slurry 
as mentioned. This stage contributed to forming nanoporosity as well, which is favourable to 
osteoinductivity. Another one in HA-G samples should be the combustion of graphite, which starts 
from 600°C and ends at 1000°C, since the temperature was consistent to the ignition temperature of 
graphite. In practical, to maximise the final quantity of in-rod microporosity or nanoporosity, the 
optimisation of sintering process for HA-G scaffolds was commenced according to the two critical 
stages, shown in Fig.2(b). Note that the sintering profile was developed on the basis of general 
sintering process [25, 32]. To be more specific, the initial holding temperature was 250°C so that the 
most of nanoporosity could be preserved after the removal of chemical reagents. In addition, another 
holding condition (900°C for 2h) was supplemented specially for complete combustion of graphite, 
so as to reduce the shrinking rate of additional in-rod porosity. In this way, it was anticipated that the 
remained amount of micro- or nano-porosity could be substantially increased. And that the actual set 
of holding temperatures was a bit higher than critical values was to ensure complete burning of 
reagents or graphite. Most of all, such optimisation turned out to work, which would be described in 
following sections. Another worth mentioning point is HA-G scaffolds were sintered with optimised 
profile, but normal scaffolds (with average amount of graphite dispersant as control) were still under 
general process to identify the potential advantages of optimised sintering process. 
3.3 Morphologies of scaffolds 
The microstructures of scaffolds were characterized by SEM. The SEM images (Fig.3) show that the 
surface of normal scaffold was much smooth in spite of little roughness; on the contrary, HA-G 
scaffolds contained massive micro and nanopores inside the filament rods, which resulted in high 
wall roughness and made the porosity hierarchical. Furthermore, great difference was found between 
HA-nG-25% and HA-μG-25% in terms of surface morphologies. Specifically, the micropores 
ranging from 30 to 100μm in size were more evident in HA-μG-25% sample, due to the utilisation of 
μG as pore former. In addition, the distribution of microporosity in HA-nG-25% was more uniform 
than μG treated scaffolds. A possible explanation is that micron graphite was more likely to be 
broken up during ultrasonic dispersion, because graphite is laminar and fragile in general. 
 In view of that nanostructures have significant influence over the biological performance of 
scaffolds, BET, which measures the specific surface area (SSA) according to physical adsorption of a 
gas on the surface, was employed to study the nano properties of normal and HA-G scaffolds. Fig.4 
presents the distribution of pores between 1 to 400nm in all scaffolds according to BET. For the 
nanopores smaller than 50nm, graphite treated scaffolds were advantageous to normal scaffolds in 
terms of SSA, owing to the optimised sintering process. So it was confirmed that such optimisation 
indeed contributed to preserving nanoporosity. Besides, considerable difference was also found in 
nanopores with larger size (100 - 400nm); that is, HA-nG-25% scaffolds shew absolute superiority in 
pore area over HA-n-c and HA-μG-25%, on account of the particle size of nG. Interestingly, in the 
range of 1 - 100nm, the SSA of HA-μG-25% was a bit higher than HA-nG-25%, although of the 
same order of magnitude. It is because more dispersant was added to get micron graphite well 
dispersed in HA slurry, while nano graphite needed less due to good dispersion. 
Now that the purpose of porogen was to produce additional in-rod porosity, the actual ratio of 
porosity and average pore size in each scale (nm, μm and mm) was listed in Table I to verify the 
formation of hierarchically porous structures. The data was beneficial to understand the overall 
distribution of porosity. And the source of data, either calculated or estimated, was demonstrated 
with footnote. From Table I we can see that the porosity of HA-n-c was almost completely (about 
98%) occupied with macropores (≥ 100μm), and the distribution of microporosity in HA-G scaffolds 
was consistent to the original of graphite. In addition, the amount of nanoporosity in HA-μG-25% 
was higher than normal scaffold, which also confirms the positive contribution made by the 
optimisation of sintering. Most of all, the average pore size in each range indicates that the structures 
were hierarchically porous. Thus it can be seen from Fig.3 and Table I that the addition of graphite as 
pore former really succeeded in creating hierarchical porosity. However, the microporosity in 
HA-nG-25% was possibly inadequate to allow full in-growth of cells [33], although further research 
is required to affirm this. So compared to HA-nG-25%, it is likely that the distribution of porosity 
and pore size in HA-μG-25% was more favourable, owing to large number of micropores. 
Table I Estimated porosity (%) and average pore size (μm) 
Porosity ≤0.4 
a
 ≥100 
b
 0.4‒100 
c
 Total 
d
  Average Size ≤0.4 
a
 ≥100 
e
 0.4‒100 
e
 
HA-n-c 0.4 ~55.8 0.6 56.8  HA-n-c 0.008 ~347 ~5 
HA-nG-25% 11.7 ~55.8 1.3 68.8  HA-nG-25% 0.132 ~326 ~15 
HA-μG-25% 0.9 ~55.8 12.7 69.4  HA-μG-25% 0.010 ~332 ~37 
a
 From BET. 
b
 Calculated by theoretical model, assuming that scaffolds could manage to keep original shapes after sintering. 
c
 By calculation of PTotal ‒ P0.4 ‒ P100. 
d
 Calculated by gravimetry method. 
e
 Measured according to SEM images. 
 
3.4 Analysis of degradation 
It is known that HA is hardly biodegradable in vivo (pH = ~7.4) in short term. Thus in order to show 
the influence of hierarchical porosity on degradation and make the degradation rate acceptable, 
acidic SBF (pH = 3) based on modified SBF [34] was prepared to accelerate the process, merely for 
the purpose of comparison (not for evaluation). Eq.(I) [35] illustrates the decomposition of HA in 
acidic environment. Weight loss and pH value (Fig.5) was monitored twice a week to record the 
process of degradation, though decomposition actually. However, due to high porosity and brittleness, 
HA scaffolds were easy to be broken up into tiny fragments especially after certain time of 
degradation (Fig.6), affecting the accuracy of weight measurement more or less (< 1.2%). 
Ca10[PO4]6[OH]2 + 8H
+ ⟶ 10Ca2+ + 6HPO4
2− + 2H2O (I) 
Fig.5 shows that only 51% was decomposed after 7 weeks in normal scaffolds, but the rate in 
HA-G scaffolds was higher (75% off HA-nG-25% and 67% off HA-μG-25%), due to extremely large 
SSA and high porosity which promotes the ability of biodegradation. Nonetheless, the degradation of 
all scaffolds exhibited similar trend, i.e. slow decomposition at initial stage and followed by 
increasing rate. It was found that HA-nG-25% scaffolds required the most frequent renewal of SBF 
solution while normal group needed the least. From the point of view of chemical reaction in Eq.(I), 
the pH value would be accordingly elevated as H
+
 was continuously consumed. Additionally, once 
the solution was refreshed, the decomposition process would be consequently accelerated in the 
following several days. To our best knowledge, the renewal of SBF surely increased the 
concentration of H
+
, and thus boosted the reaction rate, according to chemical equilibrium. Overall, 
the decomposition rate of HA scaffolds was significantly improved (≥ 31%) in HA-G scaffolds due 
to additional micro and nano porosity. It is highly likely that the actual biodegradation rate of HA-G 
scaffolds in vivo could also be accelerated at similar level, and best performance was found in 
HA-nG-25%. 
To make the process of decomposition intuitive, the appearance of scaffolds decomposed after day 
24 and 49 days was shown in Fig.6. Despite carefulness during operation, the breakup of HA 
scaffolds into fragments was still inevitable. Even worse, the more being degraded, the scaffolds 
would be more loose and brittle (Fig.6 (c) and (f)), which also was to blame for the growing 
deviation of weight loss as time went by (Fig.5). Besides, the scaffolds preferred to begin 
degradation on the edge and corner parts that possess larger SSA. 
3.5 Evaluation of bioactivity 
To evaluate the effect of microporosity features on proliferation and differentiation, the concentration 
of DNA (indicator of cell numbers) and protein/DNA ratio, which reflects cell size, was measured. 
According to Fig.7(a), the proliferation was promoted substantially in HA-G scaffolds, and the 
performance in HA-μG-25% group was improved the most (day 4). Interestingly, the number of cells 
during differentiation period in normal scaffolds was higher than the HA-G scaffolds (day 7, 
Fig.7(a)); while only slight difference was observed in protein/DNA ratio after total culture in all 
scaffolds (day 7, Fig.7(b)). It was also found that the difference of cell number (DNA) shew opposite 
trend to cell size (protein/DNA), both at day 4 and 7. This phenomenon can be explained from the 
angle of space occupancy: given that the scaffolds were fully occupied with live cells, the number of 
cells with smaller sizes would be reasonably higher than larger ones. Furthermore, the results also 
mean that HA-G scaffolds would not cause toxic effects on cells during cell culture, providing 
another evidence for successful removal of graphite after sintering. However, it needs further 
experiments to conclude the influence of porosity features on bioactivity. 
In order to know what made the difference in proliferation, SEM was employed to observe the 
initial adhesion status of myoblasts on scaffolds (1 day after cell culture). In Fig.8 (a), (c) and (e), the 
features of surface morphologies and roughness on all scaffolds were evident, also indicating 
hierarchically porous structures in HA-G scaffolds. The images show that the cells in HA-G 
scaffolds tended to adhere and spread much more freely on the surfaces, in contrast to the restricted 
and cramped adhesion on normal scaffolds. In addition, the tentacles of cells in HA-n-c could hardly 
be recognized due to poor adhesion. Whereas in HA-nG-25% and HA-μG-25% sample, the tentacles 
were more likely to join together as expected, which could build favourable foundation for cell 
interactions [36]. Another significant difference lies in the aspect of cell aggregation, wherein HA-G 
scaffolds exhibit complete superiority to normal ones, which could greatly enhance the efficiency of 
transferring biological signals [37]. Consequently, in view of adhesion, interaction and signalling, 
HA-G scaffolds were able to promote the proliferation notably during cell culture, in agreement with 
the difference of DNA concentration (day 4) in Fig.7. 
 The ability that promotes the formation of skeletal muscle during bone tissue engineering was 
evaluated to analyse the differentiation process of myoblasts through fluorescence, as shown in Fig.9, 
which illustrates the differentiation of C2C12s into multinucleated myotubes at day 7. The number of 
cells (DNA in blue) in all scaffolds was almost the same, fully in agreement with the DNA 
concentration (day 7) in Fig.7. Obviously, the formation of myotubes was definite in all scaffolds, 
owing to good biocompatibility of HA. However, the myotubes in HA-nG-25% and HA-n-c scaffold 
were still under the formative period, yet the formation stage in normal scaffold was even earlier than 
HA-nG-25%; while the formation of myotubes was much more mature to be identified. It means that 
μG treated scaffolds exerted better performance in promoting the differentiation of myoblasts into 
myotubes, compared to scaffolds treated with nG. A possible explanation is, apart from more evident 
hierarchical porosity, the distribution of porosity in HA-μG-25% scaffolds was closer to natural bone 
tissues. In addition, the micropores (30 ~ 50μm) could allow extra space for in-growth of cells, 
which are usually about 20μm in diameter [38]. The BET results also reveal that there was 
considerable amount of nanoporosity in HA-μG-25% scaffolds, which could contribute to 
osteoinductivity and bioactivity as well. 
The results in Fig.7 can be explained by further investigation into Fig.8 and 9. Due to lack of cell 
interactions, the myoblasts tends to grow up instead of increasing cell divisions to make preparation 
for differentiation [39]. So the cell number of normal scaffolds was the least and the cell size was the 
largest. On the contrary, the scaffolds treated with μG had more advantages in interactions, transfer 
of signals and more space for proliferation. Moreover, the micropores in HA-μG-25% scaffolds may 
form valid channels for the conduction of nutrition and store certain amount of nutrition inside the 
rods [40, 41], which improved the survival rate of cells. On the other hand, the decrease of cell size 
from growth media to differentiation media was getting smaller (normal > nG > μG), and the cell 
size of HA-μG-25% group was almost the same. In other words, it suggests that the cells in μG 
treated group were the most prepared for differentiation, because the cell number and size was 
extremely similar during both periods. And the formation of myotubes in Fig.9 also confirms this. 
Therefore, although cultured in differentiation media, the myoblasts in control group had to make 
more preparation for differentiation, e.g. cell division, which increases the number of cells 
dramatically with sharp decrease in cell size. As a result, the process of myoblasts differentiating into 
myotubes was “delayed”. As for HA-nG-25%, since the porosity features and the performance in 
proliferation and differentiation was between normal and μG treated scaffolds, the discussion can 
also apply to it. In conclusion, micron graphite was more suitable to serve as pore former in this 
method to fabricate bioactive scaffolds with hierarchical porosity for bone tissue engineering. 
4. Conclusions 
The hierarchically porous structures were evident in HA-G scaffolds, regardless of the different 
features and characteristics in porosity. Compared to normal scaffolds, the advantages of hierarchical 
porosity in HA-G scaffolds were substantial in terms of biological performance, including 
biodegradation, proliferation, adhesion, and differentiation. And the difference in the ratios of 
microporosity and nanoporosity would also significantly influence the performance in 
biodegradation and differentiation. However, such difference in porosity features had slight impacts 
on adhesion and proliferation. In addition, the differentiation of myoblasts into myotubes in vitro 
indicates that the distribution of pore size and porosity in HA-μG-25% was relatively more 
advantageous than HA-nG-25%, possibly because it was closer to the structures of natural bones. In 
consideration of the excellent promotion of degradation in HA-nG-25%, a mixture of micron and 
nano graphite as pore former might be the optimal for highly bioactive scaffolds. 
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Figure 1 The distribution of particle size by DLS analyser: (a) nG, (b) μG. 
Figure 2 (a) Sintering behaviour of normal and HA-G scaffold (note that TGA stands for residual mass, and DSC 
records the emission of energy during analysis), (b) optimised sintering profile for HA-G scaffolds. 
Figure 3 Morphologies of scaffolds after sintering at 1200°C: (a) HA-n-c, (b) HA-nG-25%, (c) HA-μG-25%. Scale 
bar = 100μm. 
Figure 4 BET results of SSA and pore size distribution (1 - 400 in blue means total). 
Figure 5 Degradation rate of all scaffolds in modified SBF (pH = 3; Renewed when pH ≥ 5). 
Figure 6 Scaffolds after degradation in modified SBF: HA-n-c at (a) 24 days, (b) 49 days; HA-nG-25% at (c) 24 
days, (d) 49 days; HA-μG-25% at (e) 24 days, (f) 49 days. Scale bar = 5mm. 
Figure 7 C2C12s incubated in growth media for 4 days followed by differentiation media for another 3 days: (a) 
DNA (p ≤ 0.05), (b) Protein/DNA (p ≤ 0.01). n = 3. 
Figure 8 SEM images for adhesion status of C2C12s on scaffolds (day 1): (a), (b) HA-n-c; (c), (d) HA-nG-25%; 
(e), (f) HA-μG-25%. Scale bar = 20μm. 
Figure 9 Immucytochemical images displaying multinucleated myotubes (day 7): (a) HA-n-c, (b) HA-nG-25%, (c) 
HA-μG-25%. Red (phalloidin-TRITC) ‒ F-actin, Blue (DAPI) ‒ DNA. Scale bar = 40µm. 
 
 
 




















 
